1
|
Hofstetter L, Aranovich D, Bernstine H, Hayman L, Shahal-Zimra Y, Rabizadeh E, Cohen A, Lahav M, Raanani P, Wolach O. Leukemic Phase of Histiocytic Sarcoma of the Digestive System: A Rare Manifestation of a Rare Disease. Acta Haematol 2020; 144:229-235. [PMID: 33017829 DOI: 10.1159/000509723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2020] [Accepted: 06/26/2020] [Indexed: 11/19/2022]
Abstract
Histiocytic sarcoma (HS) is a rare, malignant, and aggressive subtype of histiocytosis. We present an unusual case of aggressive HS presenting in the gastrointestinal tract and gallbladder that progressed after several lines of chemotherapy with a leukemic phase. We review the clinical, pathological, and molecular characteristics of HS in this case and review the literature on HS involving the digestive system as well as on overt leukemic phase of this disease. HS is often diagnosed at an advanced stage, and mortality is high. We discuss the therapeutic approach to patients with HS. We highlight the role of overexpression and somatic alterations in the RAF-MEK-ERK pathway in the pathogenesis of HS and discuss potential targeted approaches to treat these rare tumors.
Collapse
Affiliation(s)
- Liron Hofstetter
- Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- Institute of Hematology, Rabin Medical Center, Petah-Tikva, Israel
| | - David Aranovich
- Surgical Division, Hillel Yaffe Medical Center, Affiliated with Rappaport Medical School, Technion, Hadera, Israel
| | - Hanna Bernstine
- Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- Institute for Nuclear Medicine, Rabin Medical Center, Petah-Tikva, Israel
| | - Lucille Hayman
- Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- Institute of Pathology, Rabin Medical Center, Petah-Tikva, Israel
| | - Yael Shahal-Zimra
- Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- Cytometry Service, Rabin Medical Center, Petah-Tikva, Israel
| | - Esther Rabizadeh
- Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- Cytometry Service, Rabin Medical Center, Petah-Tikva, Israel
| | - Amos Cohen
- Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- Institute of Hematology, Rabin Medical Center, Petah-Tikva, Israel
| | - Meir Lahav
- Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- Institute of Hematology, Rabin Medical Center, Petah-Tikva, Israel
| | - Pia Raanani
- Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- Institute of Hematology, Rabin Medical Center, Petah-Tikva, Israel
| | - Ofir Wolach
- Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel,
- Institute of Hematology, Rabin Medical Center, Petah-Tikva, Israel,
| |
Collapse
|
2
|
Ferster A, Corazza F, Heimann P, Dehou MF, De Busscher C, Devalck C, Sariban E, Vamos E. Anaplastic large cell lymphoma of true histiocytic origin in an infant: unusual clinical, hematological, and cytogenetic features. Med Pediatr Oncol 1994; 22:147-52. [PMID: 8259102 DOI: 10.1002/mpo.2950220218] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
We report here the case of a 7-month-old boy who developed anaplastic large cell lymphoma of true histiocytic origin or malignant histiocytosis, with fever, bone and bone marrow infiltration. Usual clinical features were absent. The neoplastic nature of the disease was supported by the presence of clonal chromosomal abnormalities [t(6;8)(p23;p21),der(8)del(8)(q11aq13), der(22) t(11;22) (q13;13)]. Neither B nor T lineage could be demonstrated here. Morphology, ultrastructural analysis, surface antigens expression, and cytogenetics were more specific for the monocyte-macrophage lineage.
Collapse
Affiliation(s)
- A Ferster
- Haematology-Oncology Unit, Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium
| | | | | | | | | | | | | | | |
Collapse
|
3
|
Braun-falco O, Plewig G, Wolff HH, Winkelmann RK. Benign and Malignant Cutaneous Histiocytoses. Dermatology 1991. [DOI: 10.1007/978-3-662-00181-3_64] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
4
|
Abstract
A 16-month-old girl presented with hepatosplenomegaly and pancytopenia. Bone marrow aspiration showed a florid increase in macrophages with marked hemophagocytosis. She subsequently improved spontaneously with no therapeutic intervention, but 2 months later presented with frank acute monoblastic leukemia. This case illustrates the difficulties in classifying malignancies of the monocyte-macrophage lineage and how hemophagocytosis can be the presenting feature of a range of diseases.
Collapse
Affiliation(s)
- L Russell
- Department of Haematology, Royal Hospital for Sick Children, Edinburgh, Scotland
| | | | | |
Collapse
|
6
|
Abstract
The clinical and pathologic features of eight infants with monocytic leukemia are reviewed. The children were all aged 12 months or less at diagnosis and had a high incidence of extramedullary features, skin infiltration being particularly common. The diagnosis was established by conventional morphologic and cytochemical techniques. Using the French-American-British (FAB) classification, five infants had FAB 5a disease, and three had FAB 5b. The difficulties in making the diagnosis from extramedullary sites and the overlap that exists at this age between monocytic leukemia, true histiocytic lymphoma, and malignant histiocytosis are discussed. The treatments given to the group and their response are reviewed. Five of the patients received VP-16-213 and cyclophosphamide as primary induction chemotherapy, a combination that merits further evaluation in leukemia with monocytic features.
Collapse
|